Essential points from the FDA’s cautionary notice to iRhythm Technologies.
The FDA dispatched a warning letter to iRhythm Technologies, outlining numerous concerns related to the company’s Zio AT mobile cardiac telemetry device. The letter was initially sent on May 25 and subsequently posted on the agency’s website on June 6, 2023.
The letter indicated that iRhythm neglected to report two fatalities and multiple other medical device reporting (MDR) breaches to the FDA within the mandated 30-day period. The FDA additionally noted that iRhythm promoted the Zio device for unauthorized uses, implemented modifications to the device without filing the necessary documents, committed labeling errors, and failed to rectify issues pointed out in several customer complaints.
The warning letter emphasized that the obligation to comply with all relevant laws and regulations overseen by the FDA lies with the company. The FDA further stated that these problems might signal grave deficiencies in the firm’s manufacturing and quality management systems.
The FDA carried out an inspection of iRhythm’s California base in July and August 2022, engaging in discussions with the company about various infringements. The warning letter encapsulates these violations and responds to iRhythm’s counter-arguments.
For instance, the FDA’s audit unveiled that iRhythm had received a considerable volume of complaints concerning a transmission limit that hindered data transmission as planned. The FDA highlighted that this problem should have been categorized as a nonconformance since it occurred more frequently than anticipated, rendering the device incapable of its primary function of transmitting electrocardiogram data to physicians. However, iRhythm contested the FDA’s preliminary report, contending that the issue was a “design limitation and not a nonconformance.”
This transmission limit has been associated with numerous missed “significant arrhythmias,” including two fatalities. The FDA stated that iRhythm failed to report these two deaths within the obligatory 30-day period.
A critical point in the warning letter was that the Zio device was promoted for unapproved uses. The FDA has authorized it for the long-term monitoring of arrhythmia events in non-critical care patients where real-time monitoring is not essential. Yet, iRhythm’s marketing materials claimed that the device could offer “near real-time monitoring” as a “mobile cardiac telemetry monitor” and provide notifications “immediately.” These claims insinuated that Zio is approved for the treatment of high-risk patients with near real-time monitoring, which is not accurate.
iRhythm has delivered several rebuttals to the FDA regarding these violations. The FDA determined that numerous responses were satisfactory. However, some of the replies indicate that further reporting and other modifications may still be required.
Filing Wrongful Death Lawsuits for Monetary Compensation
When a loved one’s death is caused by a defective medical device, such as the alleged failures associated with iRhythm Technologies’ Zio AT mobile cardiac telemetry device, the bereaved family members may have the right to seek justice and compensation through a wrongful death lawsuit.
A wrongful death claim is a special kind of personal injury lawsuit made when someone is killed due to another party’s negligence or intentional action. In this case, if it can be proven that the Zio AT device was defective, that iRhythm was aware of these defects and did not take appropriate actions, and these defects directly led to the patient’s death, the company could potentially be held liable for wrongful death.
Filing a lawsuit involves several steps:
- Consult with an Experienced Attorney: It is crucial to consult with an experienced wrongful death attorney who understands medical device litigation. They will be able to guide you through the legal process and assess the potential for a successful case.
- Collect Evidence: You’ll need to gather all pertinent medical records, communications regarding the device (such as warnings or recalls), and any other evidence that could prove that the device was faulty and led to the death of your loved one.
- File a Complaint: Your attorney will prepare a complaint, which is a formal statement of your claims, to be filed in court. This document will outline the facts of the case, the legal basis for holding the company accountable, and the damages you are seeking.
- Discovery Process: After the complaint is filed, both sides gather information through the discovery process. This might include depositions, document requests, and more. Your attorney will help you through this process.
- Negotiation/Settlement or Trial: Many wrongful death cases are resolved through settlements, but if a settlement cannot be reached, your case will proceed to trial. Your attorney will present your case, and a judge or jury will decide the outcome.
In terms of compensation, damages awarded in wrongful death cases usually aim to cover medical and funeral costs, loss of the deceased person’s expected earnings, loss of benefits (like pension plans or medical coverage), loss of inheritance, and non-economic damages such as mental anguish and pain and suffering endured by the survivors.
Remember, every situation is unique, so it’s crucial to consult with a legal professional who can provide advice tailored to your specific circumstances.
CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW
Parker Waichman LLP helps families recover monetary compensation for harm caused by toxic substances. For your free consultation, contact our PFAS Lawsuit Lawyers today by using our live chat or calling 1-800-YOUR-LAWYER (1-800-968-7529).
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation